About this trial
Aims
1. To understand the microbial composition involved with foregut leaks 2. To define the virulence changes in the microbiota following foregut leaks 3. To identify host response mechanisms and how they change with interventions 4. Utilize this information to improve patient outcomes
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients with an esophageal or stomach leak
Over 18 years old
Disqualifiers
Patients determined by physician/surgeon as not able to tolerate biopsy
Under 18 years old
Trial design
Single group
Treatments tested in this trial
Biopsy and fluid samples
Other interventionBiopsy and fluid samples taken during other medically necessary procedure
Treatment groups
Trial outcomes
Primary outcomes
Microbial composition of samples
change in virulence factors, microbial response to treatment modalities
Time of healing of leaks
Time from index intervention to confirmed leaked closure as determined by imaging or endoscopic evaluation.
Proportion of patients achieving leak closure without need for additional surgical intervention
Successful endoscopic management will be defined as complete leak resolution without requirement for subsequent operative surgical repair. This will be measured as a percentage of participants.
Incidence of postoperative complications
Complications occurring within 30 days of surgery will be recorded. Percentage of participants with complications will be recorded.
Secondary outcomes
Patient demographics
age, sex, race, ethnicity
Patient risk of postoperative complications
Calculated by ACS risk calculator
Sponsors and contacts
Click on the lead sponsor to view all of their trials.